scholarly journals Multiplexed non-invasive tumor imaging of glucose metabolism and receptor-ligand engagement using dark quencher FRET acceptor

Theranostics ◽  
2020 ◽  
Vol 10 (22) ◽  
pp. 10309-10325
Author(s):  
Alena Rudkouskaya ◽  
Nattawut Sinsuebphon ◽  
Marien Ochoa ◽  
Sez-Jade Chen ◽  
Joseph E. Mazurkiewicz ◽  
...  
2012 ◽  
Vol 60 (3) ◽  
pp. 402-407 ◽  
Author(s):  
Bahaa Gamal Mohamed Youssif ◽  
Kensuke Okuda ◽  
Tetsuya Kadonosono ◽  
Ola Ibrahim Abdel Razek Salem ◽  
Alaa Arafat Mohamed Hayallah ◽  
...  

2016 ◽  
Vol 14 (5) ◽  
pp. 4887-4892
Author(s):  
Dae-Weung Kim ◽  
Myoung Hyoun Kim ◽  
Chang Guhn Kim

2014 ◽  
Vol 28 (5) ◽  
pp. 447-454 ◽  
Author(s):  
Dae-Weung Kim ◽  
Woo Hyoung Kim ◽  
Myoung Hyoun Kim ◽  
Chang Guhn Kim ◽  
Chang-Sok Oh ◽  
...  

2019 ◽  
Author(s):  
Alena Rudkouskaya ◽  
Nattawut Sinsuebphon ◽  
Marien Ochoa ◽  
Joe E. Mazurkiewicz ◽  
Xavier Intes ◽  
...  

AbstractFollowing an ever-increased focus on personalized medicine, there is a continuing need to develop preclinical molecular imaging modalities to guide the development and optimization of targeted therapies. To date, non-invasive quantitative imaging modalities that can comprehensively assess simultaneous cellular drug delivery efficacy and therapeutic response are lacking. In this regard, Near-Infrared (NIR) Macroscopic Fluorescence Lifetime Förster Resonance Energy Transfer (MFLI-FRET) imaging offers a unique method to robustly quantify receptor-ligand engagement in vivo and subsequent intracellular internalization, which is critical to assess the delivery efficacy of targeted therapeutics. However, implementation of multiplexing optical imaging with FRET in vivo is challenging to achieve due to spectral crowding and cross-contamination. Herein, we report on a strategy that relies on a dark quencher that enables simultaneous assessment of receptor-ligand engagement and tumor metabolism in intact live mice. First, we establish that IRDye QC-1 (QC-1) is an effective NIR dark acceptor for the FRET-induced quenching of donor Alexa Fluor 700 (AF700) using in vitro NIR FLI microscopy and in vivo wide-field MFLI imaging. Second, we report on simultaneous in vivo imaging of the metabolic probe IRDye 800CW 2-deoxyglucose (2-DG) and MFLI-FRET imaging of NIR-labeled transferrin FRET pair (Tf-AF700/Tf-QC-1) uptake in tumors. Such multiplexed imaging revealed an inverse relationship between 2-DG uptake and Tf intracellular delivery, suggesting that 2-DG signal may predict the efficacy of intracellular targeted delivery. Overall, our methodology enables for the first time simultaneous non-invasive monitoring of intracellular drug delivery and metabolic response in preclinical studies.


2013 ◽  
Vol 104 (2) ◽  
pp. 528a ◽  
Author(s):  
Judith Su ◽  
Alex Goldberg ◽  
Andrew Raubitschek ◽  
Brian Stoltz ◽  
Scott E. Fraser

2019 ◽  
Vol 47 (6) ◽  
pp. 1435-1445 ◽  
Author(s):  
Johannes Haubold ◽  
Aydin Demircioglu ◽  
Marcel Gratz ◽  
Martin Glas ◽  
Karsten Wrede ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document